Open Access Open Access  Restricted Access Subscription Access

An Overview of Monkeypox: Epidemiology, Clinical Features, Transmission, and Public Health Implications

Md. Hamza, Sunanda Sharma, Ambika Nand Jha

Abstract


Monkeypox is a zoonotic disease caused by a DNA virus within the Ortho poxvirus genus of the Poxviridae family. There are two variants of mpox, clade I and clade II, and it's quite difficult to distinguish in between them based solely on a clinical symptom. On July 23, 2022, the World Health Organization declared the monkeypox outbreak a Public Health Emergency of International Concern (PHEIC), as the majority of reported cases were from non-endemic countries. Despite extensive containment efforts, the global outbreak was attributed to the clade IIb strain has resulted in over 100,000 cases across 122 countries, with 115 of those nations having never reported mpox before. It may spread through direct contact with an infected person through skin-to-skin contact, mouth-to-mouth interactions, and close face-to-face encounters that produce infectious respiratory particles, contaminated surfaces, or infected animals. Additionally, the virus can be transmitted from the mother to the fetus during pregnancy or to the newborn during or after delivery. This infection, similar to smallpox, is primarily characterized by cutaneous manifestations, notably rashes in the genital region. In addition to dermatological symptoms, patients may experience systemic manifestations including fever, headache, lymphadenopathy, and myalgia. The disease can lead to significant complications, some of which may be severe or life-threatening, necessitating timely medical intervention and public health measures to mitigate transmission and protect vulnerable populations. This review summarizes the clinical features of monkeypox virus (MPXV), along with the laboratory techniques currently employed for its detection, Transmission and treatment guidelines.


Full Text:

PDF

References


Tollefson D, Gilman J. Actinic dermatitis: pathogenesis and management. J Dermatol. 2022;40(5):458-63. doi:10.1002/jder.17645

Bleyer A, Mathews D, Bergman J. Chronic actinic dermatitis: clinical features and management strategies. Dermatol Clin. 2023;41(4):547-57. doi:10.1016/j.det.2023.04.004

Nair B, Singh A, Kumar S. Chronic actinic dermatitis in immunosuppressed patients: case reports and management guidelines. Indian J Dermatol. 2021;66(6):523-30. doi:10.4103/ijd.ijd_526_21

Evans J, Mahmud N. Chronic actinic dermatitis: a review of pathophysiology and therapeutic options. Skin Therapy Lett. 2023;28(2):1-5.

Gupta S, Jain M, Srivastava P. Chronic actinic dermatitis: diagnostic and treatment approaches. J Clin Exp Dermatol. 2022;10(3):114-9.

Martinez L, Berson A. Long-term management strategies in chronic actinic dermatitis. J Am Acad Dermatol. 2021;84(3):752-61. doi:10.1016/j.jaad.2020.08.043

Simmons M, Farrow L, Brody H. The role of topical steroids in chronic actinic dermatitis: A systematic review. Dermatol Ther. 2023;36(1):74-80. doi:10.1111/dth.15025

Patel V, Tan J, Al-Shaikh S. Chronic actinic dermatitis: the importance of early recognition and proper treatment. Dermatology Online J. 2021;27(1):10-15.

Thompson P, Clark J, Cazacu A. Understanding the immunological mechanisms of chronic actinic dermatitis. J Immunol. 2022;213(5):1502-9. doi:10.4049/jimmunol.2100591

Tan G, Lwin Z. Role of UV radiation in the onset of chronic actinic dermatitis. Photodermatol Photoimmunol Photomed. 2023;39(2):112-7. doi:10.1111/phpp.12960


Refbacks

  • There are currently no refbacks.